Academia.edu no longer supports Internet Explorer.
To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.
2013, Iranian journal of pharmaceutical research : IJPR
Radioiodinated meta-iodobenzylguanidine (MIBG) is one of the important radiopharmaceuticals in Nuclear Medicine. [(123/131)I] MIBG is used for imaging of Adrenal medulla, studying heart sympathetic nerves, treatment of pheochromacytoma and neuroblastoma. For clinical application, radioiodinated MIBG is prepared through isotopic exchange method, which includes replacement of radioactive iodine in a nucleophilic substitution reaction with cold iodine ((127)I). The unlabelled MIBG hemisulfate is synthesized by the procedure described by Wieland et al. (1980). The availability of a more practical and cost-effective procedure for MIBG preparation encouraged us to study the MIBG synthesis methods. In this study the preparation of MIBG through different methods were evaluated and a new method, which is one step, simple and cost-effective is introduced. The method has ability to be scaled up for production of unlabelled MIBG.
Journal of Pharmacy and Pharmacology
Radiation quality-dependent bystander effects elicited by targeted radionuclides2008 •
Applied Radiation and Isotopes
Efficient production of therapeutic doses of [131I]-metaiodobenzylguanidine for clinical use2011 •
2001 •
Abstract. This paper describes the synthesis and characterization of phosphonic acid derivatives and their radiochemical studies with 186Re for the development of bone seeking radiopharmaceuticals. These ligands, when tagged with therapeutic radionuclides such as 186Re, 188Re could localize in the bone selectively. A series of αaminomethyl phosphonic acid derivatives were synthesized by a Mannich type reaction.
Therapeutic applications of radiopharmaceuticals
166 Ho labeled hydroxyapatite particles for radiosynovectomy2001 •
European Journal of Organic Chemistry
Design of Radioiodinated Pharmaceuticals: Structural Features Affecting Metabolic Stability towards in Vivo DeiodinationBioorganic & Medicinal Chemistry
Prosthetic groups for radioiodination and astatination of peptides and proteins: a comparative study of five potential bioorthogonal labeling strategies2012 •
Background 211At is one of the ideal nuclides for targeted radionuclide therapies (TRTs). Meta-[211At]astatobenzylguanidine (211At-MABG) has been proposed for the treatment of pheochromocytoma. To effectively use these radiopharmaceuticals, dosimetry must be performed. It is important to determine the absorbed doses of free 211At and 211At-MABG to determine the organs that may be at risk when using TRTs. The aim of this study was to estimate human dosimetry from preclinical biodistribution of free 211At and 211At-MABG in various organs in normal mice. Methods Male C57BL/6 N mice were administered 0.13 MBq of free 211At or 0.20 MBq of 211At-MABG by tail-vein injection. The mice were sacrificed at 5 min, and at 1, 3, 6, and 24 h after the injection (n = 5 for each group). The percentage of injected activity per mass in organs and blood (%IA/g) was determined. The human absorbed doses of free 211At and 211At-MABG were calculated using the Organ Level INternal Dose Assessment/EXponentia...
Applied Radiation and Isotopes
An alternative and expedient synthesis of radioiodinated 4-iodophenylalanine2011 •
Bioorganic & Medicinal Chemistry
A kit method for the high level synthesis of [ 211At]MABG2007 •
Bioconjugate Chemistry
Reagents for Astatination of Biomolecules. 3. Comparison of closo -Decaborate(2-) and closo -Dodecaborate(2-) Moieties as Reactive Groups for Labeling with Astatine-2112009 •
Journal of Labelled Compounds and Radiopharmaceuticals
Bioaffinity of radiolabelled neurotensin agonist and antagonist to neurotensin receptors2010 •
Nuclear Medicine and Biology
Preparation and in vivo evaluation of radioiodinated closo-decaborate(2-) derivatives to identify structural components that provide low retention in tissues2010 •
Journal of Nuclear Medicine
Targeted Radionuclide Therapy: Proceedings of a Joint Workshop Hosted by the National Cancer Institute and the Society of Nuclear Medicine and Molecular Imaging2014 •
Hormones (Athens, Greece)
The evolution in the use of MIBG scintigraphy in pheochromocytomas and paragangliomasJ. Mater. Chem. B
New targeting agent in selective drug delivery nanocarriers for treating neuroblastoma2015 •
Pediatric Blood & Cancer
Nothing but NET: A review of norepinephrine transporter expression and efficacy of 131 I-mIBG therapy2014 •
European Journal of Nuclear Medicine and Molecular Imaging
Clinical evaluation of no-carrier-added meta -[ 123 I]iodobenzylguanidine for myocardial scintigraphy2000 •
Technology in Cancer Research and Treatment
Dosimetry Study of [I-131] and [I-125]- Meta-Iodobenzyl Guanidine in a Simulating Model for Neuroblastoma Metastasis2012 •
Bioconjugate Chemistry
Streptavidin in Antibody Pretargeting. 5. Chemical Modification of Recombinant Streptavidin for Labeling with the α-Particle-Emitting Radionuclides 213 Bi and 211 At2008 •
European Journal of Nuclear Medicine and Molecular Imaging
Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma2010 •
2015 •
Nuclear Medicine and Biology
Preparation and biological evaluation of cyclopentadienyl-based 99mTc-complexes [(Cp-R)99mTc(CO)3] mimicking benzamides for malignant melanoma targeting2010 •
Journal of Medicinal Chemistry
A Novel Radioiodination Reagent for Protein Radiopharmaceuticals with l Lysine as a Plasma-Stable Metabolizable Linkage To Liberate m -Iodohippuric Acid after Lysosomal Proteolysis1997 •
Bioorganic & Medicinal Chemistry
Design of new β1-selective adrenoceptor ligands as potential radioligands for in vivo imaging2003 •
British journal of cancer
Cytotoxicity of alpha-particle-emitting astatine-211-labelled antibody in tumour spheroids: no effect of hyperthermia1998 •
European Journal of Nuclear Medicine
The diagnostic and therapeutic utility of radioiodinated metaiodobenzy1guanidine (MIBG)1990 •
Journal of Gene Medicine
An efficient targeted radiotherapy/gene therapy strategy utilising human telomerase promoters and radioastatine and harnessing radiation-mediated bystander effects2004 •
Nuclear medicine and biology
Astatine-211-labeled biotin conjugates resistant to biotinidase for use in pretargeted radioimmunotherapy1998 •
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology
Therapeutic nuclear medicine in pediatric malignancy2010 •
Nuclear Medicine and Biology
Meta-iodobenzyl guanidine for detection and staging of neuroendocrine tumors2008 •
Bioorganic Medicinal Chemistry
Design of new beta1-selective adrenoceptor ligands as potential radioligands for in vivo imaging2003 •
Targeted oncology
The status of radioimmunotherapy in CD20+ non-Hodgkin's lymphoma2015 •
Journal of medicinal chemistry
Synthesis and evaluation of radioiodinated acyloxymethyl ketones as activity-based probes for cathepsin B2014 •
Basic Research in Cardiology
18F-labelled cardiac PET tracers: selected probes for the molecular imaging of transporters, receptors and proteases2008 •
Applied radiation and …
Synthesis and evaluation of radioiodinated substituted [beta]-naphthylalanine as a potential probe for pancreatic [beta]-cells imaging2006 •
Nuclear Medicine and Biology
Evaluation of an anti-p185HER2 (scFv-CH2-CH3)2 fragment following radioiodination using two different residualizing labels: SGMIB and IB-Mal-D-GEEEK2009 •
European Journal of Nuclear Medicine and Molecular Imaging
EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy2008 •
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Effects of active chronic cocaine use on cardiac sympathetic neuronal function assessed by carbon-11-hydroxyephedrine1997 •
Journal of Nuclear Medicine
MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of -Particle Emitters for Targeted Radionuclide Therapy2010 •
Pediatric Blood & Cancer
Biodistribution of post-therapeutic versus diagnostic131I-MIBG scans in children with neuroblastoma2004 •
Applied Radiation and Isotopes
N-[2-(maleimido)ethyl]-3-(trimethylstannyl)benzamide, a molecule for radiohalogenation of proteins and peptides2015 •
European Journal of Nuclear Medicine and Molecular Imaging
Non-invasive in vivo imaging with radiolabelled FIAU for monitoring cancer gene therapy using herpes simplex virus type 1 thymidine kinase and ganciclovir2004 •